TY - JOUR
T1 - Enhancement and suppression of DTH reactivity to rauscher murine leukaemia virus induced tumour cell lines
AU - Knulst, A. C.
AU - Berends, D.
AU - Bazuin, C.
AU - van Rooij, H. C.J.
AU - de Both, N. J.
AU - Benner, R.
PY - 1989/9
Y1 - 1989/9
N2 - Delayed-type hypersensitivity (DTH) to Rauscher murine leukaemia virus (R-MuLV) encoded or induced determinants was induced in mice by three syngeneic R-MuLV-induced tumour cell lines, i.e. a myeloid tumour, RMB-1, an erythroid tumour, RED-1, and a lymphoid tumour, RLD-1. DTH to subcutaneously (s.c.) administered RMB-1 cells appeared on day 4, with a maximum DTH response on day 6 or 7. The induction of DTH could be prevented by intravenous (i.v.) pre-immunisation with R-MuLVinduced tumour cells several days before the s.c. immunisation. The three R-MuLV-induced tumour cell lines showed cross-reactivity in the DTH assay, whereas no cross-reactivity was found with syngeneic WEHI-3 cells. This indicates that the three R-MuLV-induced tumour cell lines share a virally encoded or induced antigenic determinant, which activates T-cells. When the RMB-1 cells used for immunisation had been cultured in medium supplemented with interferon-γ (IFN-γ), the subsequent DTH response was increased. This coincided with an increased expression of the R-MuLV-specific antigenic determinants on RMB-1 cells as demonstrated by Scatchard analysis. Furthermore, IFN-γ increased the MHC class I antigen expression on RMB-1 cells, whereas the class II antigen expression remained undetectable.
AB - Delayed-type hypersensitivity (DTH) to Rauscher murine leukaemia virus (R-MuLV) encoded or induced determinants was induced in mice by three syngeneic R-MuLV-induced tumour cell lines, i.e. a myeloid tumour, RMB-1, an erythroid tumour, RED-1, and a lymphoid tumour, RLD-1. DTH to subcutaneously (s.c.) administered RMB-1 cells appeared on day 4, with a maximum DTH response on day 6 or 7. The induction of DTH could be prevented by intravenous (i.v.) pre-immunisation with R-MuLVinduced tumour cells several days before the s.c. immunisation. The three R-MuLV-induced tumour cell lines showed cross-reactivity in the DTH assay, whereas no cross-reactivity was found with syngeneic WEHI-3 cells. This indicates that the three R-MuLV-induced tumour cell lines share a virally encoded or induced antigenic determinant, which activates T-cells. When the RMB-1 cells used for immunisation had been cultured in medium supplemented with interferon-γ (IFN-γ), the subsequent DTH response was increased. This coincided with an increased expression of the R-MuLV-specific antigenic determinants on RMB-1 cells as demonstrated by Scatchard analysis. Furthermore, IFN-γ increased the MHC class I antigen expression on RMB-1 cells, whereas the class II antigen expression remained undetectable.
UR - https://www.scopus.com/pages/publications/0024421360
U2 - 10.1038/bjc.1989.284
DO - 10.1038/bjc.1989.284
M3 - Article
C2 - 2477052
AN - SCOPUS:0024421360
SN - 0007-0920
VL - 60
SP - 351
EP - 357
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 3
ER -